We are live on ! Find out more
Janus Henderson Group

Janus Henderson Group Portfolio holdings

AUM $209B
1-Year Est. Return 37.72%
 

Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.

This Fund
S&P 500
This Quarter Est. Return
+10.9%
1 Year Est. Return
+37.72%
3 Year Est. Return
+117.83%
5 Year Est. Return
+153.46%
10 Year Est. Return
+660.32%
AUM
$140B
AUM Growth
-$127B
Cap. Flow
-$148B
Cap. Flow %
-105.67%
Top 10 Hldgs %
21.76%
Holding
2,666
New
131
Increased
291
Reduced
1,907
Closed
210

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$8.38B
2
AAPL icon
Apple
AAPL
+$5.7B
3
AMZN icon
Amazon
AMZN
+$3.72B
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.64B
5
MA icon
Mastercard
MA
+$3.47B

Sector Composition

Rank Sector Weight
1 Technology 28.11%
2 Healthcare 21.42%
3 Financials 11.42%
4 Industrials 10.73%
5 Consumer Discretionary 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRUE
2501
DELISTED
TrueCar
TRUE
-37,944
Closed -$58K
TYRA icon
2502
Tyra Biosciences
TYRA
$1.97B
-1,364,036
Closed -$12M
UI icon
2503
Ubiquiti
UI
$32.3B
-33,324
Closed -$9.78M
VERV
2504
DELISTED
Verve Therapeutics
VERV
-7,268
Closed -$250K
VMBS icon
2505
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.5B
-66,906
Closed -$3.02M
VXRT
2506
DELISTED
Vaxart
VXRT
-47,944
Closed -$104K
ZIMV
2507
DELISTED
ZimVie
ZIMV
-2,181,712
Closed -$21.5M
ZVSA
2508
DELISTED
ZyVersa Therapeutics
ZVSA
-600
Closed -$2.1M
ASTH icon
2509
Astrana Health
ASTH
$1.82B
-6,153
Closed -$241K
VSEE
2510
VSee Health
VSEE
$4.01M
-118,386
Closed -$1.2M
NBIS
2511
Nebius Group N.V.
NBIS
$47.8B
$0 ﹤0.01%
15,658
-15,658
-50%
EXE
2512
Expand Energy Corp
EXE
$21.4B
-44,358
Closed -$4.18M
TBCH
2513
Turtle Beach Corp
TBCH
$243M
-22,644
Closed -$156K
FFAI
2514
Faraday Future Intelligent Electric
FFAI
$13.7M
0
-$30K
CMRX
2515
DELISTED
Chimerix, Inc.
CMRX
-29,622
Closed -$58K
PYCR
2516
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
-6,930
Closed -$205K
GATE
2517
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
-170,372
Closed -$1.7M
KACL
2518
DELISTED
Kairous Acquisition Corp. Limited Ordinary Shares
KACL
-359,612
Closed -$3.62M
AY
2519
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
-125,842
Closed -$3.31M
DNMR
2520
DELISTED
Danimer Scientific, Inc.
DNMR
-723
Closed -$86K
VBIV
2521
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
-2,222
Closed -$48K
ASTR
2522
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
-3,339
Closed -$32K
BLUA.U
2523
DELISTED
BlueRiver Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-third of a redeemable Warrant to acquire one Class A ordinary shares
BLUA.U
-113,936
Closed -$1.13M
CNGL
2524
DELISTED
Canna-Global Acquisition Corp. Class A Common Stock
CNGL
-400,000
Closed -$4.05M
ADTH
2525
DELISTED
AdTheorent Holding Co
ADTH
-80,652
Closed -$172K

Similar funds

Janus Henderson Group's Q4 2022 Portfolio in Review

As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.

  • Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
  • Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
  • Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
  • Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
  • Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
  • Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
  • Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.

Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.